MDLN Financials

Income Statement
MetricQ2 2026Q1 2026
Revenue
7.7B
+4.5%
7.4B
Cost of Revenue
5.5B
-0.7%
5.5B
Gross Profit
2.2B
+20.3%
1.8B
Operating Expenses
1.8B
+28.3%
1.4B
R&D
0
0
SG&A
1.3B
+5.5%
1.2B
Operating Income
395.0M
-6.4%
422.0M
EBITDA
651.0M
-3.7%
676.0M
Net Income
139.0M
-41.8%
239.0M
EPS (Basic)
$0.07
-56.3%
$0.16
EPS (Diluted)
$0.07
-56.3%
$0.16
Shares (Diluted)
860.9M
+4.4%
824.8M
Medline (MDLN) โ€” Financials